Evaluation of the effects of food on the single-dose pharmacokinetics of trametinib, a first-in-class MEK inhibitor, in patients with cancer.
about
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas.Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumoursTrametinib in the treatment of melanoma.Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors.
P2860
Evaluation of the effects of food on the single-dose pharmacokinetics of trametinib, a first-in-class MEK inhibitor, in patients with cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Evaluation of the effects of f ...... itor, in patients with cancer.
@en
Evaluation of the effects of f ...... itor, in patients with cancer.
@nl
type
label
Evaluation of the effects of f ...... itor, in patients with cancer.
@en
Evaluation of the effects of f ...... itor, in patients with cancer.
@nl
prefLabel
Evaluation of the effects of f ...... itor, in patients with cancer.
@en
Evaluation of the effects of f ...... itor, in patients with cancer.
@nl
P2093
P2860
P356
P1476
Evaluation of the effects of f ...... itor, in patients with cancer.
@en
P2093
Amita Patnaik
Anthony Tolcher
Carolyn Pendry
Daniele Ouellet
Donna S Cox
John Bauman
Keith Orford
Kyri Papadopoulos
Patricia LoRusso
P2860
P304
P356
10.1002/JCPH.115
P577
2013-07-25T00:00:00Z